Printer Friendly

Browse Respiratory agents topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Switzerland : Major study published in NEJM confirms Novartis' Ultibro Breezhaler superiority over Seretide in preventing COPD exacerbations. May 16, 2016 345
Global Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights 2016 - Research and Markets. May 5, 2016 559
Global Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights 2016 - Research and Markets. May 5, 2016 519
Global Lung Cancer Market and Competitive Landscape Overview 2016-2020 - Research and Markets. May 4, 2016 495
Global Lung Cancer Market and Competitive Landscape Overview 2016-2020 - Research and Markets. May 4, 2016 535
Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2016. May 3, 2016 489
Procurement of respiratory drugs for ccl hospitals. Apr 30, 2016 133
Edison Initiates Coverage on Adherium. Apr 20, 2016 601
Advances in Inhaled Drug Delivery Offer Major Benefits to Patients, Chief Scientific Officer for Pulmatrix Explains in Article. Apr 19, 2016 1253
Metered Dose Inhaler Medical Device Pipeline Industry Assessment 2016 Market Research Report. Apr 18, 2016 1167
Smoking, viral infection reduce efficacy of lung medications. Apr 12, 2016 243
Lancet Publication: New Analysis Demonstrates Only Small Minority of Severe/Very Severe COPD Patients May Benefit from Adding ICS to SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) + LABA Therapy. Apr 8, 2016 1788
equipments instruments for dbt twinning project deptt of respiratory medicine:Gene Xpert machine, Breath Collection Apparatus. Apr 3, 2016 113
RE-PHARM RECEIVES SECOND UK PATENT. Mar 31, 2016 288
United States : Tagrisso (osimertinib) approved in Japan for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer. Mar 30, 2016 496
United States : Transgenomic to present data confirming utility of ICE COLD-PCR Liquid Biopsy Technology at American Association for Cancer Research 2016 annual meeting. Mar 30, 2016 676
Pulmatrix's iSPERSE 'Inhaled' Drug Delivery Technology Offers Hope to Patients with Pulmonary Lung Disease. Mar 23, 2016 676
Extension of tender for equipments required for department of pulmonary medicine. Mar 15, 2016 144
VERONA PHARMA PLC - Positive results from RPL554 dose-finding study. Clinical report Mar 15, 2016 2140
Pulmatrix Reports 2015 Financial Results; Provides 2016 Outlook on Pulmonary Disease Pipeline. Financial report Mar 10, 2016 4080
Inari Medical Announces IDE Approval To Study The FlowTriever System For The Treatment Of Pulmonary Embolism. Mar 8, 2016 643
Xencor Initiates Two Phase 2 Trials of XmAb5871 in IgG4-Related Disease and Systemic Lupus Erythematosus. Mar 7, 2016 1542
Providing services for sanatorium treatment of citizens, recipients of social services in 2016 on the profile of the treatment of respiratory diseases. Mar 4, 2016 149
Procurement of medicine-respiratory. Mar 3, 2016 106
Cough lozenges with cough suppressant like dextromethorphan or any local aneshthetic like menthol/levomenthol for sore throat. Mar 1, 2016 213
FDA approves new indication for Novartis drug Afinitor for progressive, nonfunctional GI and lung neuroendocrine tumors (NET). Feb 26, 2016 2620
Supply and installation of equipments/instruments for use of respiratory medicine, rims, imphal. Feb 24, 2016 135
Number 092 provision for sanatorium treatment of citizens - recipients of social services in the profile treatment of respiratory diseases. Feb 20, 2016 183
United States : CAPSUGEL and Pulmatrix team up on Pulmonary Disease Treatments. Feb 20, 2016 148
Mylan's ANDA for Generic Advair Diskus Accepted for Filing by FDA. Feb 19, 2016 939
Small Cell Lung Cancer Treatment Industry Epidemiology Forecast to 2024 Research Report Available at WiseGuyReports.com. Report Feb 12, 2016 927
Providing Services For The Spa Treatment Of Respiratory Diseases To Certain Categories Of Citizens Residing In The Territory Of The Samara Region, Included In The Federal Register Of Persons Entitled. Feb 12, 2016 199
Egalet Signs Agreement with Septodont, Inc. to Promote SPRIX (ketorolac tromethamine) Nasal Spray to Dentists in United States. Feb 8, 2016 1675
Construction of Respiratory Medicine ward in 2nd floor over the Existing 10 Bedded Neo-Natal Ward and pediatric ward in Government Medical college Hospital at Thoothukudi Dist. Feb 7, 2016 129
SPIRIVA RESPIMAT Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents. Disease/Disorder overview Feb 3, 2016 2015
Bonnie J. Addario Lung Cancer Foundation Honors Bristol-Myers Squibb for Improving and Advancing Breakthrough Treatments for Lung Cancer. Feb 3, 2016 873
Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD. Feb 1, 2016 1066
Resolution of vocal fold leukoplakia during erlotinib treatment for lung cancer. Francis, David O.; Misono, Stephanie; Somerville, Jessica; McWhorter, Andrew; Garrett, C. Gaelyn Case study Feb 1, 2016 1897
Medicines - respiratory. Jan 30, 2016 105
Combination Inhalers for Upper Airway Diseases : Products, Markets and Forecasts. Jan 28, 2016 478
This Biotech Company Gives an Old Drug an Exciting New Lease on Life. Jan 27, 2016 3223
Procurement of respiratory drugs for ccl hospitals. Jan 27, 2016 134
Equipments required for Department of Pulmonary Medicine. Jan 22, 2016 132
Equipments required for department of pulmonary medicine. Jan 22, 2016 140
FDA Approves New Kyprolis (Carfilzomib) Combination Therapy For The Treatment Of Patients With Relapsed Or Refractory Multiple Myeloma. Jan 21, 2016 4389
Europe Non-Small Cell Lung Cancer Treatments Market to Cross US$ 3 Billion by 2019 Says Pharmaion. Jan 18, 2016 686
Europe Non-Small Cell Lung Cancer Treatments Market to Cross US$ 3 Billion by 2019 Says Pharmaion. Jan 18, 2016 690
Procurement of Respiratory Drugs for CCL Hospitals. Jan 16, 2016 104
Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2015. Jan 12, 2016 534
Mylan Confirms FDA Submission of ANDA for Generic Advair Diskus. Jan 11, 2016 353
Jama Neurology Releases Highly Promising Data From ALS Clinical Trial Conducted By Hadassah Medical Organization Jerusalem And Brainstorm Cell Therapeutics. Jan 11, 2016 1257
Jama Neurology Releases Highly Promising Data From ALS Clinical Trial Conducted By Hadassah Medical Organization Jerusalem And Brainstorm Cell Therapeutics. Jan 11, 2016 1220
Phoenix PharmaLabs Releases New Data Confirming That Their Novel Opioid Shows No Signs of Addiction Potential. Jan 6, 2016 946
Switzerland : Novartis Pharmaceuticals collaborates with Qualcomm in digital innovation with the Breezhaler(TM) inhaler device to treat COPD. Jan 6, 2016 521
Europe Asthma Market Highlights - Analysis & Opportunities Report 2015-2020. Report Dec 22, 2015 550
Europe Asthma Market Highlights - Analysis & Opportunities Report 2015-2020. Report Dec 22, 2015 556
A/A in existing two rooms to develop day care ward for the department of pulmonary medicine at 3rd floor of New Private Wards building at AIIMS. Dec 16, 2015 102
Egalet Signs Agreement with Teva Pharmaceutical Industries to Commercialize SPRIX (ketorolac tromethamine) Nasal Spray in Select Geographies Outside the United States. Dec 14, 2015 1220
Purchase of Medical Thoracoscope for the Department of Pulmonary Medicine(Re-Tender). Dec 10, 2015 131
Purchase of sleep diagnostic mechine for the department of pulmonary medicine(re-tender). Dec 10, 2015 131
Amgen Submits Application In Europe To Expand Indication Of Kyprolis (carfilzomib) For The Treatment Of Relapsed Multiple Myeloma. Clinical report Dec 5, 2015 3880
Propeller Health Announces Development Agreement and R&D Collaboration with GSK to Develop a Digital Sensor for the Ellipta Inhaler. Dec 1, 2015 769
Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: a comparative, randomized, double-blind, placebo-controlled study. Barth, Anders; Hovhannisyan, Areg; Jamalyan, Kristina; Narimanyan, Mikael Report Dec 1, 2015 6461
Anesthetics, respiratory medicines, immunoglobulin, etc. Nov 28, 2015 124
Salt Therapy recommended by Local Chemists for treatment of respiratory problems including Asthma, Bronchitis, Sinusitis and COPD; Advertising Feature. Disease/Disorder overview Nov 27, 2015 1422
United Kingdom : Asthma treatment from Circassia set for approval. Nov 26, 2015 199
United States : FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose. Nov 20, 2015 916
LABAs show no benefit over tiotropium in black adults. Smith, Jennie Nov 15, 2015 400
Antitussive, expectorant, and bronchodilating effects of quinazoline alkaloids ([+ or -])-vasicine, deoxyvasicine, and ([+ or -])-vasicinone from aerial parts of Peganum harmala L. Liu, Wei; Wang, Yongli; He, Dan-dan; Li, Shu-ping; Zhu, Yu-dan; Jiang, Bo; Cheng, Xue-mei; Wang, Zhe Report Nov 15, 2015 5150
Anesthetics, respiratory medicines, immunoglobulin, etc. Nov 5, 2015 118
United States : FDA approves Nucala to treat severe asthma. Nov 5, 2015 530
New Salt Therapy recommended by Jhoots Pharmacists for treatment of respiratory problems including Asthma, Sinusitis and COPD. Nov 4, 2015 1423
Mallinckrodt's INOmax Approved In Australia And Japan For Pulmonary Hypertension In Conjunction With Heart Surgery. Oct 30, 2015 1503
FDA approves new Novartis dual combination bronchodilator Utibron(TM) Neohaler for patients with chronic obstructive pulmonary disease. Oct 29, 2015 2998
Drugs for respiratory system treatment. Oct 26, 2015 102
New Salt Therapy recommended by Scottish Pharmacists for treatment of respiratory problems including Asthma, Sinusitis and COPD. Oct 17, 2015 1295
Provision of purchase of supplies of drug supply warehouse, as memorandun no. 915 dated 27 july 2015. andacollo hospital. Oct 17, 2015 178
Supply of medicinal products - drugs (digestive system, respiratory system drugs, cardiovascular drugs, nervous system drugs, hormones, drugs, etc.) from the list of packages in quantities resulting f. Oct 17, 2015 155
FDA Approves Praxbind (idarucizumab), Specific Reversal Agent for Pradaxa (dabigatran etexilate mesylate). Oct 16, 2015 2681
Provision of Respiratory medicines. Oct 16, 2015 131
Patara Pharma Closes a $26 million Series A Financing and Initiates Phase II Clinical Trials to Evaluate PA101B for Refractory Chronic Cough and Indolent Systemic Mastocytosis. Oct 12, 2015 975
Annual Operation And Maintenance Of Effulent Treatment Plant At Kamla Nehru Hospital And Pulmonary Medicine Centre, Jehangirabad, Gas Rahat, Bhopal. Oct 9, 2015 127
Gateway Analytical and Next Breath Partner to Present Webinar Series Focused on Formulation Development for Inhalable and Nasal Drug Products. Oct 7, 2015 669
Israel : Teva buys US-based respiratory disease compliance startup. Oct 6, 2015 276
Invion Successfully Completes Phase 2 Study of INV102 (Nadolol) to Aid Smoking Cessation. Oct 5, 2015 1204
Repairing of cassette type split ac units in pulmonary medicine and geriatric medicine ward at aiims. Oct 5, 2015 129
NIH Awards $1.7 Million Grant for Celdara Medical and Pulmatrix to Develop an Inhaled Biologic Treatment for Idiopathic Pulmonary Fibrosis. Oct 1, 2015 1212
Supply of medicinal products - drugs (digestive system, respiratory system drugs, cardiovascular drugs, nervous system drugs, hormones, drugs, etc.) from the list of packages in quantities resulting f. Oct 1, 2015 153
Recommendations for the use of endoscopic lung volume reduction in South Africa: role in the treatment of emphysema. Koegelenberg, C.F.N.; Theron, J.; Dheda, K.; Bruwer, J.W.; Allwood, B.W.; Vorster, M.J.; von Groote- Report Oct 1, 2015 4950
PTC Therapeutics Submits European Application For Translarna(TM) for Cystic Fibrosis. Sep 30, 2015 1559
Tunitas Therapeutics Closes $10 Million Series A Financing. Sep 30, 2015 649
Egalet Provides Commercial Update on SPRIX Nasal Spray and OXAYDO(TM) Along with Pipeline Review at Investor Day. Sep 29, 2015 1043
Germany : Landmark year for Boehringer Ingelheim s respiratory portfolio - new data for COPD, IPF and asthma treatments. Sep 22, 2015 366
Germany : ERS 2015 Landmark year for Boehringer Ingelheim s respiratory portfolio new data for COPD, IPF and asthma treatments. Sep 21, 2015 708
Equipments For Pulmonary Medicine Department. Sep 19, 2015 112
New Salt Therapy recommended by Liverpool chemists for treatment of respiratory problems including Asthma, Sinusitis and COPD. Disease/Disorder overview Sep 18, 2015 1180
FDA Grants Priority Review for Amgen's Supplemental New Drug Application for Expanded Labeling of Kyprolis (Carfilzomib) in Relapsed Multiple Myeloma. Sep 18, 2015 3651
Egalet Announces Investor Day. Sep 15, 2015 790
Egalet Announces Scientific Data at PAINWeek 2015 Meeting Supports Analgesic Efficacy of SPRIX Nasal Spray Versus Commonly Prescribed Oral Combination Opioids in Treatment of Moderate to Severe Short-Term Pain. Sep 10, 2015 1244
DelMar Pharmaceuticals Presents Clinical Protocol for Advancement of VAL-083 into Phase IV Studies as a Treatment for Non-Small Cell Lung Cancer. Sep 8, 2015 1899
Provision of f1586) drugs respiratory and cardiovascular sys. Sep 8, 2015 123
Orally Inhaled Corticosteroids to 2022. Sep 7, 2015 654
Orally Inhaled Bronchodilators to 2022. Sep 7, 2015 696
Pulmatrix Issued New Composition of Matter Patent Covering iSPERSE(TM) Technology. Sep 2, 2015 905
Inhaled Drug Delivery Seminar - London, UK - November 19-20, 2015. Sep 2, 2015 223
Inhaled Drug Delivery Seminar - London, UK - November 19-20, 2015. Sep 2, 2015 263
Egalet Announces Scientific Presentations at PainWeek 2015 Meeting. Sep 1, 2015 1485
U.S. FDA APPROVES ZUBSOLV FOR OPIOID DEPENDENCE. Sep 1, 2015 923
Making provision for temporary shed for storing consumable itmes of respiratory medicines of ward-32 at sjh, new delhi. Sep 1, 2015 115
Making Provision For Temporary Shed For Storing Consumable Itmes Of Respiratory Medicines Of Ward-32 At Sjh, New Delhi. Sep 1, 2015 111
EPIGEN: EPIGEN: A New Predictive Response Test for Non Small Cells Lung Cancer Treatment. Aug 28, 2015 264
Asthma and COPD Market Set to Grow Leading to Surge in Demand for Combination Inhalers for Upper Airway Diseases. Aug 25, 2015 631
Asthma and COPD Market Set to Grow Leading to Surge in Demand for Combination Inhalers for Upper Airway Diseases. Aug 25, 2015 671
Drugs for respiratory system treatment. Aug 12, 2015 145
Asthma Treatment Drugs Markets in China. Aug 5, 2015 419
Lung Cancer Treatment Drugs Markets in China. Aug 5, 2015 420
Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review. Jul 29, 2015 1380
FDA Approves Kyprolis (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma. Jul 24, 2015 3707
Adherium & AstraZeneca Partner to Improve the Lives of Individuals with Respiratory Disease. Jul 23, 2015 1048
Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF). Jul 6, 2015 944
Annual Repair work for Painting, Distempering, White Washing in Pulmonary Medicine Centre at Jehangirabad, Bhopal for the one year. Jul 6, 2015 135
Atopix Therapeutics Secures Funding to Broaden Development of CRTH2 Antagonists for TH2-Mediated Disease. Jun 17, 2015 1027
Atopix Therapeutics Secures Funding to Broaden Development of CRTH2 Antagonists for TH2-Mediated Disease. Jun 17, 2015 1033
Pulmatrix and Mylan Enter Into ex-U.S. Development Agreement for PUR0200. Jun 16, 2015 1067
Asthma sufferers 'being put at risk' warns charity. Jun 16, 2015 294
Warning over asthma inhaler prescriptions. Jun 16, 2015 609
Global Pediatric Drugs and Vaccines Market. Jun 10, 2015 7412
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets. Jun 8, 2015 534
Steroid injections don't help in asthma, says Omani doctor. Jun 6, 2015 277
Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation 2015: Market Landscape to Grow in Diversity over Coming Years. Jun 4, 2015 780
Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation 2015: Market Landscape to Grow in Diversity over Coming Years. Jun 4, 2015 786
Syp. antitussive. Jun 2, 2015 117
New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market. Jun 1, 2015 735
New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market. Jun 1, 2015 740
Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations. May 29, 2015 753
Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations. May 29, 2015 758
FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD. May 26, 2015 3964
Novartis investigational dual bronchodilator significantly improved lung function compared to single bronchodilators in patients with moderate-to-severe COPD in phase III studies. May 20, 2015 3196
Inhaled Drug Delivery to 2022 : Drugs, Devices, Markets and Forecasts. May 19, 2015 456
Orally Inhaled Bronchodilators to 2022. May 19, 2015 338
Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference. Conference news May 18, 2015 2406
Elsevier Presents the Sixth Edition of Murray & Nadel's Textbook of Respiratory Medicine at 2015 American Thoracic Society Conference. May 15, 2015 892
Elsevier Presents the Sixth Edition of Murray & Nadel's Textbook of Respiratory Medicine at 2015 American Thoracic Society Conference. May 15, 2015 896
Supply of Ophthalmology Norvmydriatic Retinal Camera & Analysis System ,Ophthalmology Portable Auto refractometer,Ophthalmology Trabeculoplasty Laser,Pulmonary Medicine Portable Spirometry System,Pulm. May 15, 2015 124
Cuba launches revolutionary drug to treat lung cancer; US in deal to turn it into vaccine. May 13, 2015 353
Cuba launches revolutionary drug to treat lung cancer; US in deal to turn it into vaccine. May 13, 2015 348
Merck Receives FDA Fast Track Designation for Evofosfamide for Treatment of Patients Living With Advanced Pancreatic Cancer. May 12, 2015 1388
Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer. May 12, 2015 1432
EMA Releases Draft Opinion on Two Patient-Reported Outcome (PRO) Measures for Evaluating New Treatments for COPD. May 11, 2015 542
EMA Releases Draft Opinion on Two Patient-Reported Outcome (PRO) Measures for Evaluating New Treatments for COPD. May 11, 2015 567
Spyryx Biosciences Secures $18 Million in Series A Financing. May 7, 2015 780
The supply of medical equipment for the sub-carpathian lung diseases centre in rzeszEw as part of the program titled mz. "improving standards of surgical treatment and lung cancer combined - retrofitt. May 6, 2015 162
FDA approves BREO ELLIPTA for the treatment of adults with asthma in the US. Apr 30, 2015 2948
Majority of lung cancer treatment decisions are not guided by patient's genetic makeup, according to new international survey. Apr 22, 2015 1249
People with diabetes should know that... cough medicine could help. Apr 21, 2015 149
DelMar Pharmaceuticals Presents Positive Preclinical Data on VAL-083 for Treatment of Non-Small Cell Lung Cancer at the American Association of Cancer Research Annual Meeting. Apr 19, 2015 1839
Panel backs ICS/LABA combo for asthma in adults. Mechcatie, Elizabeth Apr 15, 2015 904
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets. Apr 14, 2015 540
Global Orally Inhaled Corticosteroids Market Report 2015-2022. Apr 9, 2015 524
Global Orally Inhaled Bronchodilators Market to 2022. Apr 9, 2015 653
Global Orally Inhaled Corticosteroids Market Report 2015-2022. Apr 9, 2015 551
Global Orally Inhaled Bronchodilators Market to 2022. Apr 9, 2015 680
DelMar Pharmaceuticals Announces Panel Participation in Cancer Advance Boston Conference on April 14, 2015. Conference news Apr 7, 2015 949
Alexander Chi, MD Involved in Groundbreaking Lung Cancer Treatment Studies. Mar 27, 2015 486
Egalet Provides Commercial Update on SPRIX and OXAYDO(TM). Mar 25, 2015 2038
Selten Pharma, Inc. Receives Orphan Drug Designation From U.S. FDA for the Treatment of Pulmonary Arterial Hypertension. Mar 18, 2015 771
LUNGevity Foundation Celebrates Women Making History in Science. Mar 10, 2015 930
Syp. antitussive. Mar 3, 2015 117
DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083. Mar 2, 2015 1047
Vitamin D3 and asthma. Mar 1, 2015 582
Novel vaccines effective against poultry diseases. Avant, Sandra Mar 1, 2015 473
Supply of various medicinal products including antibacterial agents that reduce blood clotting, for the treatment of respiratory, vaccines, mineral additives, immunoglobulin products to treat nervous. Feb 27, 2015 356
Launch of Turing Pharmaceuticals Announced - New Drug Company to Focus on Treating Unmet Medical Needs Across Broad Therapeutic Areas. Feb 24, 2015 894
Cardiovascular and Respiratory Medicines. Feb 24, 2015 177
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status. Feb 21, 2015 1714
Cardiovascular and Respiratory Medicines. Feb 20, 2015 181
United Kingdom : GSK and Theravance announce start of phase III lung function study with closed triple combination treatment FF/UMEC/VI for COPD. Report Feb 10, 2015 366
University Of Maryland Medicine Announces New National Program In Lung Healing To Develop Innovative Approaches For Preventing And Treating Acute Lung Disease. Feb 6, 2015 2544
United States : Mylan shoulders way into blockbuster market for COPD treatments. Feb 4, 2015 145
FDA panel rejects oral desmopressin for nocturia. Mechcatie, Elizabeth Feb 1, 2015 977
Serendex Pharmaceuticals And CMC Biologics Enter Exclusive Agreement On Factor VIIa. Jan 30, 2015 748
Serendex Pharmaceuticals And CMC Biologics Enter Exclusive Agreement On Factor VIIa. Jan 30, 2015 717
Xencor Reports XmAb7195 Top-line Interim Phase 1a Results Showing Rapid Reduction of Serum IgE in Healthy Volunteers. Jan 29, 2015 2025
U.S. FDA Approves IMBRUVICA (ibrutinib) for Treatment of Waldenstrom's macroglobulinemia (WM). Jan 29, 2015 2959
U.S. FDA Approves IMBRUVICA (ibrutinib) for the Treatment of Waldenstrom's Macroglobulinemia: First FDA-Approved Therapy for This Disease. Jan 29, 2015 2263
Tender document for rate contract for supply and installation of diffusion system, spirometer, thoracoscopy system and ebus at pulmonary medicine department at aiims bhopal. Jan 28, 2015 113
GSK expands its portfolio of medicines in the US for patients with asthma and COPD. Jan 26, 2015 1837
SPIRIVA RESPIMAT (tiotropium bromide) Inhalation Spray Now Available in the United States. Jan 21, 2015 1662
Cough suppressant may ease fibromyalgia pain. Jan 9, 2015 449
U.S. FDA Approves Daiichi Sankyo's Once-Daily SAVAYSA(TM) (edoxaban) Tablets for Reduction of Stroke Risk in Non-Valvular Atrial Fibrillation and for the Treatment of Venous Thromboembolism. Jan 8, 2015 4096
Inhaled COPD Therapeutics. Dec 12, 2014 598
Inhaled Asthma Therapeutics. Dec 12, 2014 611
Inhaled CNS Therapeutics. Dec 12, 2014 685
Inhaled COPD Therapeutics. Dec 12, 2014 625
Inhaled Asthma Therapeutics. Dec 12, 2014 638
Inhaled CNS Therapeutics. Dec 12, 2014 712
Dry Powder Inhalers to 2020. Dec 12, 2014 677
Dry Powder Inhalers to 2020. Dec 12, 2014 683
Apellis Pharmaceuticals Raises $33M to Fund its Complement Immunotherapy Programs. Dec 2, 2014 1111
Global Pulmonary Drug Delivery Systems Market 2015-2019: Key Vendors are AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Philips Healthcare. Dec 2, 2014 780
Global Pulmonary Drug Delivery Systems Market 2015-2019: Key Vendors are AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Philips Healthcare. Dec 2, 2014 809
Antemortem diagnosis and successful treatment of pulmonary candidiasis in a sun conure (Aratinga solstitialis). Proenca, Laila M.; Mayer, Jorg; Schnellbacher, Rodney; Sanchez, Susan; Huang, Chien-Tsun; Brown, Hol Report Dec 1, 2014 2508
Asthma Treatment Market (Drug) Worth $23 Billion by 2023. Nov 28, 2014 1464
Asthma Treatment Market (Drug) Worth $23 Billion by 2023. Nov 28, 2014 1468
Online Marketing Will Be a Boon for the Global Pulmonary Drug Delivery Systems Market From 2015 to 2019. Nov 18, 2014 874
Online Marketing Will Be a Boon for the Global Pulmonary Drug Delivery Systems Market From 2015 to 2019. Nov 18, 2014 880
LAMA/LABA topped fluticasone/salmeterol in COPD. Worcester, Sharon Nov 15, 2014 690
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market. Nov 12, 2014 457
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market. Nov 12, 2014 463
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market : Novel Inhaler Devices and Formulations are Impetuses for Growth. Nov 10, 2014 624
Germany : Boehringer Ingelheim announces U.S. FDA filing acceptance of NDA for Spiriva Respimat in asthma. Nov 5, 2014 170
Boehringer Ingelheim Announces U.S. Filing Acceptance of New Drug Application for Spiriva Respimat (tiotropium bromide) Inhalation Spray for the Treatment of Asthma. Nov 3, 2014 2068
Celsion Presents Preclinical Data for its TheraSilence(TM) Platform at the miRNA World Conference Workshop on miRNA Delivery. Conference news Oct 29, 2014 979
Boehringer Ingelheim Presents Data for the Co-Administration of Two Approved Products for COPD Patients. Oct 27, 2014 2477
Global Pediatric Drugs and Vaccines Market. Oct 23, 2014 6077
Buy cough medicine? Don't waste your money, honey; Home-made remedy just as effective, say docs. Oct 16, 2014 140
In the Face of Sales Erosion of Key Brands by Novel Formulations, GlaxoSmithKline/Theravance's LABA/LAMA Anoro Will Become the Leading COPD Agent in 2023. Drug overview Oct 15, 2014 682
Pulmonary Drug Delivery Systems: Technologies and Global Markets 2014. Oct 14, 2014 1050
Support for Healthcare Professionals in Tackling the Burden of Symptomatic Asthma. Oct 8, 2014 689
New COPD Maintenance Treatment Striverdi Respimat (olodaterol) Inhalation Spray Now Available in U.S. Pharmacies. Oct 8, 2014 1565
DelMar Pharmaceuticals Announces Presentations at Upcoming Scientific Meetings. Oct 6, 2014 510
Common Medications for Lung Diseases Hospital Leon Daniello Cluj-Napoca. Oct 5, 2014 441
Lightlake Therapeutics Inc. Announces Closing Of Investments In Two Products. Oct 2, 2014 917
Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps. Sep 30, 2014 2056
ASCO 2014 -- Delegate Physicians Rate Influence and Impact. Sep 30, 2014 1057
PharmaPoint: Asthma - Japan Drug Forecast and Market Analysis to 2023. Sep 30, 2014 562
CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer. Sep 29, 2014 1507
Boehringer Ingelheim Announces FDA Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for the Maintenance Treatment of COPD. Sep 25, 2014 1842
Germany : Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherap. Sep 19, 2014 417
Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy. Sep 18, 2014 3005
Oxford Finance Closes $20 Million Debt Facility with Pulmonx. Sep 17, 2014 416
United Kingdom : GSK data presented at ERS demonstrate potential of blood eosinophil levels to help inform COPD treatment decisions. Sep 9, 2014 259
New Phase III Study Shows Investigational Tiotropium Improves Lung Function in Adolescent Patients with Symptomatic Asthma. Sep 8, 2014 2153
Boehringer Ingelheim Presents Pivotal Phase III Data for the Investigational Fixed-Dose Combination of Tiotropium + Olodaterol in COPD. Sep 8, 2014 1749
Japan : Ant-cancer agent Alecensa capsules introduced by Chugai Pharma. Sep 8, 2014 380
Switzerland : Novartis to unveil new data from three key clinical trials at European Respiratory Society International Congress 2014. Sep 3, 2014 298
Germany : Boehringer Ingelheim to present comprehensive data supporting broad respiratory portfolio in COPD, asthma and IPF at ERS 2014. Sep 2, 2014 298
Ekos nabs FDA OK for its pulmonary embolism treatment device. Sep 1, 2014 323
United Kingdom : GSK receives FDA approval for Arnuity Ellipta (fluticasone furoate) in the USA for the treatment of asthma. Aug 22, 2014 304
Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms. Aug 21, 2014 679
GSK receives FDA approval for Arnuity(TM) Ellipta (fluticasone furoate) in the US for the treatment of asthma. Aug 20, 2014 924
Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD. Aug 19, 2014 2156
FDA Advisory Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD. Aug 14, 2014 1485
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF). Aug 5, 2014 594
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF). Aug 5, 2014 599
Concordia Healthcare Corp. initiates Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN[R]. Aug 5, 2014 1189
Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk of Death at One Year among Stable COPD Patients. Clinical report Aug 4, 2014 908
Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk of Death at One Year among Stable COPD Patients. Clinical report Aug 4, 2014 915
FDA Approves Boehringer Ingelheim's Striverdi Respimat (olodaterol) Inhalation Spray for Maintenance Treatment of COPD. Aug 1, 2014 1508
Drugs for Lung Disease Work With Body Clock. Jul 28, 2014 480
Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma. Jul 24, 2014 679
Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse. Jul 23, 2014 726
United Kingdom : Intertek co-author study on inhaled medicine test procedures. Report Jul 22, 2014 331
Children's growth 'being stunted by asthma inhalers'. Jul 18, 2014 288
Asthma Inhalers Can Stunt Child Growth. Jul 18, 2014 363
New genes identified to help in asthma treatment. Jul 9, 2014 289
United Kingdom,United States : Anoro Ellipta (umeclidinium/vilanterol) gains approval in Japan for the treatment of COPD. Jul 7, 2014 446
Japan,United Kingdom : Anoro Ellipta(umeclidinium/vilanterol) gains approval in Japan for the treatment of COPD. Jul 4, 2014 436
United Kingdom : GSK and Theravance announce submission to US regulatory authorities for fluticasone furoate/vilanterol in asthma. Jul 1, 2014 324
Bellerophon Therapeutics Completes Enrollment of its Phase 2 Trial of INOpulse For Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease (PH-COPD). Jun 26, 2014 807
Pulmonary Drug Delivery Systems Market (Products - Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications - Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019. Jun 23, 2014 2089
Emerging Therapies for Previously Treated EGFR Wild-Type/Untested Non-Small-Cell Lung Cancer are Expected to Offer Efficacy Benefits Over Current Treatments. Jun 19, 2014 656
Asmacure Announces Top-Line Clinical Results for ASM-024 DPI in Ph 1/2a Trial. Financial report Jun 18, 2014 1192
Hunterdon Regional Cancer Center: The Only Cancer Center in New Jersey to Offer Immuno-Therapy Clinical Trial for Lung Cancer. Jun 11, 2014 743
DelMar Pharmaceuticals, Inc. Presentation Now Available for On-Demand viewing at RetailInvestorConferences.com. Jun 9, 2014 689
Yoga may not be of much help to asthma sufferers. Jun 3, 2014 197
Parion Sciences Announces Senior Leadership and Organizational Changes. Jun 2, 2014 814
AADI SIGNS LICENSING AGREEMENT WITH CELGENE. Jun 1, 2014 412
Fears for kids over asthma inhalers. Jun 1, 2014 185
Drugs approved in 2013. Briggs, Gerald G. Jun 1, 2014 1467
Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA). May 29, 2014 1548
Xencor Initiates Phase 1 Study of XmAb7195 for Asthma. May 28, 2014 751
Immune Design's GLAAS(TM) Discovery Platform Used in MEDI7510 Phase 1 Trial for Respiratory Syncytial Virus. May 27, 2014 631
New Potential Antibody Treatment for Asthma Discovered. May 23, 2014 445
DelMar Pharmaceuticals to Present at the Third Annual Marcum LLP MicroCap Conference. Conference news May 22, 2014 781
Singapore : ASLAN PHARMACEUTICALS obtains global license to develop Asthma Treatment. May 22, 2014 213
Potential asthma treatment discovered. May 21, 2014 342
Boehringer Ingelheim Presents First Phase 3 Data on Fixed-Dose Combination of Tiotropium Plus Olodaterol in COPD. May 21, 2014 1480
AADi Announces Licensing Agreement with Celgene for Nanotechnology-Based Drug Candidate. May 20, 2014 684
The New England Journal Of Medicine Publishes Positive Proof-Of-Concept Data For New Asthma Treatment. Clinical report May 20, 2014 2113
Vitamin D has limited benefits in asthma treatment. May 19, 2014 404
Leading Pulmonologists Draw National Media Focus to Endobronchial Coil Treatment for Severe Emphysema. May 19, 2014 1028
Ataluren Phase 3 Trial Results in Nonsense Mutation Cystic Fibrosis Published in The Lancet Respiratory Medicine. May 16, 2014 1724
Prosonix to Present Results of Phase 2 Clinical Study of PSX1002 in Chronic Obstructive Pulmonary Disease (COPD) at the American Thoracic Society Meeting. Clinical report May 15, 2014 1010
Prosonix to Present Results of Phase 2 Clinical Study of PSX1002 in Chronic Obstructive Pulmonary Disease (COPD) at the American Thoracic Society Meeting. Clinical report May 15, 2014 1006
DelMar Pharmaceuticals to Present Interim Clinical Data for Ongoing VAL-083 Glioblastoma Multiforme Trial at ASCO. May 14, 2014 563
FLUIDDA'S Technology Assists in Optimizing Treatment for COPD Patients. May 9, 2014 270
FLUIDDA'S Technology Assists in Optimizing Treatment for COPD Patients. May 9, 2014 274
United Kingdom : Anoro (umeclidinium/vilanterol) gains marketing authorisation in Europe for the treatment of COPD. May 9, 2014 348
Study Shows No Benefit From Active Ingredient In Common Cold Medicine. May 8, 2014 540
United Kingdom : GSK receives approval for Incruse Ellipta (umeclidinium) in the US for the treatment of COPD. May 2, 2014 334
Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors. Apr 30, 2014 508
GSK receives approval for Incruse(TM) Ellipta (umeclidinium) in the US for the treatment of COPD. Apr 30, 2014 1162
United Kingdom : GSK receives EU marketing authorisation for Incruse (umeclidinium) for the treatment of COPD. Apr 29, 2014 452
Anoro(TM) Ellipta now available in the US for treatment of COPD. Apr 28, 2014 2169
Erdosteine Received Orphan Drug Status by the FDA. Apr 28, 2014 1006
Greater Reductions in Exacerbations Remains an Open Area of Opportunity in the Chronic Obstructive Pulmonary Disease Market. Apr 24, 2014 691
Genoa Pharmaceuticals and McMaster University demonstrate inhaled pharmacokinetics enables improved pirfenidone activity with significant promise to enhance IPF treatment safety and tolerability. Apr 21, 2014 627
COPD Drug Market Opportunity and Clinical Pipeline Analysis. Apr 19, 2014 1284
COPD Drug Market Opportunity and Clinical Pipeline Analysis. Apr 19, 2014 1289

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters